Automated High Throughput Trypsin Digests for Highly Reproducible Peptide Map Analysis

The extended capabilities of LC/MS characterization for biotherapeutics have put increasing strain on throughput and efficiency. Highly reproducible LC/MS measurements of biopharmaceuticals may therefore be at risk from processes that are not reproducible, independent of the analytical technique. Automation of default workflows can address variability and improve analytical efficiency in the modern biopharmaceutical industry.